{"transactions":[{"id":711404,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-11T01:53:28.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":24400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from July 8, 2026, with the first annual vest occurring on July 8, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount has been adjusted to reflect the cancellation of 5,750 restricted stock units for no consideration, which is exempt from Section 16 pursuant to Rule 16b-6(d) and Rule 16a-4(d) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":35025,"source":{"system":"sec-edgar","filing":"0000905148-26-003238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514826003238/form4.xml","form_type":"4"}},{"id":772913,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T00:49:03.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":16375,"source":{"system":"sec-edgar","filing":"0000905148-26-002531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514826002531/form4.xml","form_type":"4"}},{"id":1125992,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T22:19:50.000Z","date":"2025-06-01","kind":"exercise","planned":false,"acquired":true,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Due to clerical error, this amendment to Form 4 is being filed to correct the transaction code in the reported transaction."},{"field":"shares","element":"transactionShares","label":"F2","text":"As reported in the original Form 4, reflects the release of restricted stock units that were previously reported on a Form 4."}],"balance_after":131023,"source":{"system":"sec-edgar","filing":"0001077183-25-000132","document":"wk-form4a_1748989184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000132/wk-form4a_1748989184.xml","form_type":"4/A","original_submission_date":"2025-06-03"}},{"id":1125979,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-03T20:07:32.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":23077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":23077,"derivative":{"exercise_price":0,"exercise_date":"2026-06-01","underlying":"Common Stock","underlying_shares":23077},"source":{"system":"sec-edgar","filing":"0001077183-25-000126","document":"wk-form4_1748981239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000126/wk-form4_1748981239.xml","form_type":"4"}},{"id":1125978,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2025-06-03T20:07:32.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":16107,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16107,"derivative":{"exercise_price":7.28,"exercise_date":"2026-06-01","expiration_date":"2035-06-01","underlying":"Common Stock","underlying_shares":16107},"source":{"system":"sec-edgar","filing":"0001077183-25-000126","document":"wk-form4_1748981239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000126/wk-form4_1748981239.xml","form_type":"4"}},{"id":1125977,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-03T20:07:32.000Z","date":"2025-06-01","kind":"exercise","planned":false,"acquired":false,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-06-01","underlying":"Common Stock","underlying_shares":12254},"source":{"system":"sec-edgar","filing":"0001077183-25-000126","document":"wk-form4_1748981239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000126/wk-form4_1748981239.xml","form_type":"4"}},{"id":1125976,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:07:32.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":131023,"source":{"system":"sec-edgar","filing":"0001077183-25-000126","document":"wk-form4_1748981239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000126/wk-form4_1748981239.xml","form_type":"4"}},{"id":1132345,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-28T21:26:55.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":3000,"derivative":{"exercise_price":18.95,"expiration_date":"2035-05-23","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000905148-25-001932","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514825001932/form4.xml","form_type":"4"}},{"id":1132344,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-28T21:26:55.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number has been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024."}],"balance_after":10625,"source":{"system":"sec-edgar","filing":"0000905148-25-001932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514825001932/form4.xml","form_type":"4"}},{"id":1435181,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-08-13T20:24:12.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":false,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-08-10","underlying":"Common Stock","underlying_shares":11336},"source":{"system":"sec-edgar","filing":"0001077183-24-000127","document":"wk-form4_1723580646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000127/wk-form4_1723580646.xml","form_type":"4"}},{"id":1435180,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:24:12.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":true,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":118769,"source":{"system":"sec-edgar","filing":"0001077183-24-000127","document":"wk-form4_1723580646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000127/wk-form4_1723580646.xml","form_type":"4"}},{"id":1493337,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-04T20:07:58.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":12254,"derivative":{"exercise_price":0,"exercise_date":"2025-06-01","underlying":"Common Stock","underlying_shares":12254},"source":{"system":"sec-edgar","filing":"0001077183-24-000092","document":"wk-form4_1717531670.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000092/wk-form4_1717531670.xml","form_type":"4"}},{"id":1493336,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2024-06-04T20:07:58.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":8672,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8672,"derivative":{"exercise_price":13.71,"exercise_date":"2025-06-01","expiration_date":"2034-06-01","underlying":"Common Stock","underlying_shares":8672},"source":{"system":"sec-edgar","filing":"0001077183-24-000092","document":"wk-form4_1717531670.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000092/wk-form4_1717531670.xml","form_type":"4"}},{"id":1499440,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T23:20:11.000Z","date":"2024-05-25","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":0.9075,"expiration_date":"2034-05-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000905148-24-001652","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514824001652/form4.xml","form_type":"4"}},{"id":1499439,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-29T23:20:11.000Z","date":"2024-05-25","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":81250,"source":{"system":"sec-edgar","filing":"0000905148-24-001652","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514824001652/form4.xml","form_type":"4"}},{"id":1809013,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-08-14T21:41:33.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":11336,"derivative":{"exercise_price":0,"exercise_date":"2024-08-10","underlying":"Common Stock","underlying_shares":11336},"source":{"system":"sec-edgar","filing":"0001077183-23-000121","document":"wk-form4_1692049280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000121/wk-form4_1692049280.xml","form_type":"4"}},{"id":1809012,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2023-08-14T21:41:33.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":8353,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8353,"derivative":{"exercise_price":14.82,"exercise_date":"2024-08-10","expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":8353},"source":{"system":"sec-edgar","filing":"0001077183-23-000121","document":"wk-form4_1692049280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000121/wk-form4_1692049280.xml","form_type":"4"}},{"id":1831082,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T22:45:23.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":1.32,"expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-23-034282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036123034282/form4.xml","form_type":"4"}},{"id":1831081,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-12T22:45:23.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001140361-23-034282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036123034282/form4.xml","form_type":"4"}},{"id":2203768,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-07-21T20:09:25.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":5602,"price":1.4219,"value":7965.4838,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSU of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 22,500 restricted stock units."}],"balance_after":31898,"source":{"system":"sec-edgar","filing":"0001567619-22-014297","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922014297/doc1.xml","form_type":"4"}},{"id":2203767,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-07-21T20:09:25.000Z","date":"2022-07-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Performance Stock Units (\"PSUs\") initially granted on October 24, 2021 that were subject to a performance-based vesting condition. The first milestone vesting condition was determined to be satisfied upon which 50% of the PSUs vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 22,500 restricted stock units."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001567619-22-014297","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922014297/doc1.xml","form_type":"4"}},{"id":2233092,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T00:42:18.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":13882,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13882,"derivative":{"exercise_price":8.1,"exercise_date":"2023-06-10","expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":13882},"source":{"system":"sec-edgar","filing":"0001077183-22-000110","document":"wf-form4_165525372464364.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000110/wf-form4_165525372464364.xml","form_type":"4"}},{"id":2233091,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-15T00:42:18.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":15556,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":107433,"source":{"system":"sec-edgar","filing":"0001077183-22-000110","document":"wf-form4_165525372464364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000110/wf-form4_165525372464364.xml","form_type":"4"}},{"id":2260447,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T21:50:13.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest monthly over one (1) year from the date of grant subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":2.01,"expiration_date":"2032-05-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-22-020304","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036122020304/form4.xml","form_type":"4"}},{"id":2260446,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-23T21:50:13.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":31250,"source":{"system":"sec-edgar","filing":"0001140361-22-020304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000114036122020304/form4.xml","form_type":"4"}},{"id":2411402,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T21:51:36.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":135000,"derivative":{"exercise_price":4.13,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001567619-22-002523","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922002523/doc1.xml","form_type":"4"}},{"id":2411401,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-04T21:51:36.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 22,500 RSUs."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001567619-22-002523","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922002523/doc1.xml","form_type":"4"}},{"id":2534386,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Performance Stock Units (PSUs)","published_at":"2021-10-26T20:24:19.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-21-018716","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921018716/doc1.xml","form_type":"4"}},{"id":2534385,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-26T20:24:19.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":40000,"derivative":{"exercise_price":5.34,"expiration_date":"2031-10-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001567619-21-018716","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921018716/doc1.xml","form_type":"4"}},{"id":2681544,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T00:00:00.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":3714,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3714,"derivative":{"exercise_price":40.9,"exercise_date":"2022-06-02","expiration_date":"2028-06-02","underlying":"Common Stock","underlying_shares":3714},"source":{"system":"sec-edgar","filing":"0001077183-21-000162","document":"wf-form4_162285118004344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000162/wf-form4_162285118004344.xml","form_type":"4"}},{"id":2681543,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-05T00:00:00.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":3081,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91877,"source":{"system":"sec-edgar","filing":"0001077183-21-000162","document":"wf-form4_162285118004344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000162/wf-form4_162285118004344.xml","form_type":"4"}},{"id":2701354,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-22T01:11:45.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors."}],"balance_after":7500,"derivative":{"exercise_price":3.64,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001179110-21-005772","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911021005772/edgar.xml","form_type":"4"}},{"id":2701353,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-22T01:11:45.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the reporting person's continuous service on the Company's Board of Directors."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001179110-21-005772","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911021005772/edgar.xml","form_type":"4"}},{"id":2708656,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T23:01:10.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in equal monthly installments over the shorter of three years from the date of grant or the period beginning on the date the Reporting Person was appointed to the Company's Board of Directors and ending on the date of the annual meeting at which the Reporting Person is first considered for election by the stockholders, provided that the Reporting Person continues to provide service."}],"balance_after":80000,"derivative":{"exercise_price":3.71,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001179110-21-005550","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911021005550/edgar.xml","form_type":"4"}},{"id":2818997,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T22:00:25.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 26, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":175000,"derivative":{"exercise_price":7.85,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001567619-21-005398","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921005398/doc1.xml","form_type":"4"}},{"id":3063867,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-10T22:22:14.000Z","date":"2020-08-06","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 25, 2017, Alison Hannah was granted 10,000 stock options.  The options vested ratably on the next three anniversary dates of the grant date."}],"balance_after":0,"derivative":{"exercise_price":7.27,"expiration_date":"2022-05-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001077183-20-000181","document":"wf-form4_159709812032905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000181/wf-form4_159709812032905.xml","form_type":"4"}},{"id":3063866,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-10T22:22:14.000Z","date":"2020-08-06","kind":"exercise","acquired":true,"shares":10000,"price":7.27,"value":72700.0,"ownership":{"direct":true},"balance_after":88796,"source":{"system":"sec-edgar","filing":"0001077183-20-000181","document":"wf-form4_159709812032905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000181/wf-form4_159709812032905.xml","form_type":"4"}},{"id":3129504,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-01T23:38:03.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":3448,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3448,"derivative":{"exercise_price":28.54,"exercise_date":"2021-05-28","expiration_date":"2027-05-28","underlying":"Common Stock","underlying_shares":3448},"source":{"system":"sec-edgar","filing":"0001077183-20-000135","document":"wf-form4_159105466369083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000135/wf-form4_159105466369083.xml","form_type":"4"}},{"id":3129503,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-01T23:38:03.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":2698,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":78796,"source":{"system":"sec-edgar","filing":"0001077183-20-000135","document":"wf-form4_159105466369083.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000135/wf-form4_159105466369083.xml","form_type":"4"}},{"id":3288210,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-05T20:44:14.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Inducement Option Award will vest and become exercisable as to 25% of the total number of shares subject to the option on February 3, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":7.71,"expiration_date":"2030-02-02","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001567619-20-002230","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920002230/doc1.xml","form_type":"4"}},{"id":3417843,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T00:00:00.000Z","date":"2019-09-09","kind":"exercise","acquired":false,"shares":8333,"price":9.11,"value":75913.63,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 28, 2016, Alison Hannah was granted 8,333 stock options.  The options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":0,"derivative":{"exercise_price":9.11,"exercise_date":"2017-07-28","expiration_date":"2021-07-28","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001077183-19-000168","document":"wf-form4_156824638474713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000168/wf-form4_156824638474713.xml","form_type":"4"}},{"id":3417842,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T00:00:00.000Z","date":"2019-09-09","kind":"exercise","acquired":false,"shares":3333,"price":6.66,"value":22197.78,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 15, 2015 Alison Hannah was granted 10,000 stock options, the options vest ratably on the next three anniversary dates of the grant date."}],"balance_after":0,"derivative":{"exercise_price":6.66,"exercise_date":"2016-07-15","expiration_date":"2020-07-15","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001077183-19-000168","document":"wf-form4_156824638474713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000168/wf-form4_156824638474713.xml","form_type":"4"}},{"id":3417841,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-12T00:00:00.000Z","date":"2019-09-09","kind":"exercise","acquired":true,"shares":8333,"price":9.11,"value":75913.63,"ownership":{"direct":true},"balance_after":76098,"source":{"system":"sec-edgar","filing":"0001077183-19-000168","document":"wf-form4_156824638474713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000168/wf-form4_156824638474713.xml","form_type":"4"}},{"id":3417840,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-12T00:00:00.000Z","date":"2019-09-09","kind":"exercise","acquired":true,"shares":3333,"price":6.66,"value":22197.78,"ownership":{"direct":true},"balance_after":67765,"source":{"system":"sec-edgar","filing":"0001077183-19-000168","document":"wf-form4_156824638474713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000168/wf-form4_156824638474713.xml","form_type":"4"}},{"id":3496116,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-06-11T01:15:51.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":4269,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4269,"derivative":{"exercise_price":22.52,"exercise_date":"2020-06-06","expiration_date":"2026-06-06","underlying":"Common Stock","underlying_shares":4269},"source":{"system":"sec-edgar","filing":"0001077183-19-000108","document":"wf-form4_156021573544544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000108/wf-form4_156021573544544.xml","form_type":"4"}},{"id":3496115,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-11T01:15:51.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":3419,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64432,"source":{"system":"sec-edgar","filing":"0001077183-19-000108","document":"wf-form4_156021573544544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000108/wf-form4_156021573544544.xml","form_type":"4"}},{"id":3906218,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T21:44:43.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":3017,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3017,"derivative":{"exercise_price":11.6,"exercise_date":"2019-06-01","expiration_date":"2023-06-01","underlying":"Common Stock","underlying_shares":3017},"source":{"system":"sec-edgar","filing":"0001077183-18-000043","document":"wf-form4_152823502163988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000043/wf-form4_152823502163988.xml","form_type":"4"}},{"id":3906217,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:44:43.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":15564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61013,"source":{"system":"sec-edgar","filing":"0001077183-18-000043","document":"wf-form4_152823502163988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000043/wf-form4_152823502163988.xml","form_type":"4"}},{"id":4195634,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-03T21:19:40.000Z","date":"2017-08-09","kind":"other","acquired":false,"shares":6667,"price":6.66,"value":44402.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 15, 2015 Alison Hannah was granted 10,000 stock options, the options vest ratably on the next three anniversary dates of the grant date.  On 8/9/2017 6,667 of these options were exercised leaving a balance of 3,333."}],"balance_after":3333,"derivative":{"exercise_price":6.66,"exercise_date":"2016-07-15","expiration_date":"2020-07-15","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001209191-17-055258","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117055258/doc4.xml","form_type":"4"}},{"id":4195633,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T21:19:40.000Z","date":"2017-08-09","kind":"exercise","acquired":true,"shares":6667,"price":6.66,"value":44402.22,"ownership":{"direct":true},"balance_after":45449,"source":{"system":"sec-edgar","filing":"0001209191-17-055258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117055258/doc4.xml","form_type":"4"}},{"id":4248702,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-31T21:25:35.000Z","date":"2017-07-27","kind":"purchase","acquired":true,"shares":20000,"price":9.19,"value":183800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the average purchase price of shares purchased on July 27, 2017."}],"balance_after":38782,"source":{"system":"sec-edgar","filing":"0001209191-17-046748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117046748/doc4.xml","form_type":"4"}},{"id":4301759,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2017-05-31T01:09:42.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":8667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date."}],"balance_after":8667,"derivative":{"exercise_date":"2017-06-30","underlying":"Common Stock","underlying_shares":8667},"source":{"system":"sec-edgar","filing":"0001209191-17-036314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036314/doc4.xml","form_type":"4"}},{"id":4301758,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-31T01:09:42.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":10000,"price":7.27,"value":72700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On May 25, 2017, Alison Hannah was granted 10,000 stock options.  The options vest ratably on the next three anniversary dates of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":7.27,"exercise_date":"2018-05-25","expiration_date":"2022-05-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-036314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036314/doc4.xml","form_type":"4"}},{"id":4301757,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2017-05-31T01:09:42.000Z","date":"2017-05-30","kind":"exercise","acquired":false,"shares":5072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017."}],"balance_after":0,"derivative":{"exercise_date":"2016-09-30","expiration_date":"2017-03-31","underlying":"Common Stock","underlying_shares":5072},"source":{"system":"sec-edgar","filing":"0001209191-17-036314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036314/doc4.xml","form_type":"4"}},{"id":4301756,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2017-05-31T01:09:42.000Z","date":"2017-05-30","kind":"exercise","acquired":false,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017."}],"balance_after":0,"derivative":{"exercise_date":"2016-06-30","expiration_date":"2017-03-31","underlying":"Common Stock","underlying_shares":2150},"source":{"system":"sec-edgar","filing":"0001209191-17-036314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036314/doc4.xml","form_type":"4"}},{"id":4301755,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":31067,"kind":"person","name":"HANNAH ALISON L.","position":1,"cik":"0001645600","reported_name":"HANNAH ALISON L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T01:09:42.000Z","date":"2017-05-30","kind":"exercise","acquired":true,"shares":7222,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18782,"source":{"system":"sec-edgar","filing":"0001209191-17-036314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036314/doc4.xml","form_type":"4"}}]}